Comments

Chimerix Stock Price, Quotes and Forecasts

Q: What sector and industry does Chimerix (CMRX) operate in?

Chimerix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CMRXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$8.52

0.020.24%

At close: -

$8.51

-0.01000-0.12%

After Hours: 6:21 PM EDT

Chimerix (CMRX) Forecast

News Earnings Chimerix (CMRX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Chimerix Stock Price, Quotes and Forecasts | NASDAQ:CMRX | Benzinga

Explore Chimerix stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CMRX.

Open	$8.52
Close	$8.52
Volume / Avg.	1.35M / 3.92M
Day Range	$8.51 - $8.53
52 Wk Range	0.75 - 8.53
Market Cap	$798.27M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	83
Short Interest	3.83%
Days to Cover	1

Recent News

This MongoDB Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday

Avi Kapoor

Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline

Jazz Pharmaceuticals will add dordaviprone, a potential treatment for a rare brain tumor, to its growing oncology pipeline.

Vandana Singh

S&P 500 Edges Lower; AutoZone Posts Downbeat Earnings

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$8.52
Close	$8.52
Volume / Avg.	1.35M / 3.92M
Day Range	$8.51 - $8.53
52 Wk Range	0.75 - 8.53
Market Cap	$798.27M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	83
Short Interest	3.83%
Days to Cover	1

About Chimerix Inc

Sector

Health Care

Industry

Biotechnology

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Chimerix (CMRX) stock?

You can purchase shares of Chimerix (NASDAQ:CMRX) through any online brokerage.

View our list of the best stock brokerages

Who are Chimerix (CMRX) competitors?

Other companies in Chimerix’s space includes: 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT), Replimune Group (NASDAQ:REPL) and Prothena Corp (NASDAQ:PRTA).

What is the forecast, or price target, for Chimerix (CMRX) stock?

Chimerix has a consensus price target of $7.60.

What is the current price for Chimerix (CMRX)?

The stock price for Chimerix (NASDAQ: CMRX) is $8.51 last updated April 2, 2025 at 6:21 PM EDT.

Does Chimerix (CMRX) pay a dividend?

There are no upcoming dividends for Chimerix.

When is Chimerix (NASDAQ:CMRX) reporting earnings?

Chimerix’s Q1 earnings are confirmed for Wednesday, April 30, 2025.

Is Chimerix (CMRX) going to split?

There is no upcoming split for Chimerix.

What sector and industry does Chimerix (CMRX) operate in?

Chimerix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.